The Ukrainian pharmaceutical market grew last year, despite the reduction of purchasing power of local consumers which was observed in 2013, according to an official report of the Ukrainian Ministry of Health.
Last year, the market grew by 12.55 % to 30 billion hryvnia ($3.75 billion), in value terms, compared to 2012. At the same time in volume terms the growth was only 0.79% and reached 1.3 billion packages.
According to representatives of the Ukrainian Ministry of Industry and Trade, despite the achieved growth, 2013 became not the best year for the domestic pharmaceutical market for the last several years, as the growth of the market, which has been observed in recent years, has significantly declined.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze